Pharmacotherapy for diabetic coronary disease
This presentation is the property of its rightful owner.
Sponsored Links
1 / 34

Pharmacotherapy for Diabetic Coronary Disease: PowerPoint PPT Presentation


  • 46 Views
  • Uploaded on
  • Presentation posted in: General

Pharmacotherapy for Diabetic Coronary Disease: . Trials Targeting Lower HbA 1c Levels. VADT: CV Risk Factor Control. Look AHEAD: Lifestyle Intervention Did Not Reduce Hard End Points . UKPDS: Metformin and Outcomes in New T2D at 36 Months.

Download Presentation

Pharmacotherapy for Diabetic Coronary Disease:

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Pharmacotherapy for diabetic coronary disease

Pharmacotherapy for Diabetic Coronary Disease:


Trials targeting lower hba 1c levels

Trials Targeting Lower HbA1c Levels


Vadt cv risk factor control

VADT: CV Risk Factor Control


Look ahead lifestyle intervention did not reduce hard end points

Look AHEAD: Lifestyle Intervention Did Not Reduce Hard End Points


Ukpds metformin and outcomes in new t2d at 36 months

UKPDS: Metformin and Outcomes in New T2D at 36 Months


Advance reducing hba 1c lowers microvascular events

ADVANCE: Reducing HbA1c Lowers Microvascular Events


Vadt intensive treatment reduces cvd events in cases with lower calcified coronary atherosclerosis

VADT: Intensive Treatment Reduces CVD Events in Cases With Lower Calcified Coronary Atherosclerosis


Look ahead earlier intervention beneficial

Look AHEAD: Earlier Intervention Beneficial?


Savor timi 53 and examine conclusions

SAVOR-TIMI 53 and EXAMINE: Conclusions


Changes in microalbuminuria

Changes in Microalbuminuria


Baseline nt probnp and hospitalization for heart failure

Baseline NT-proBNP and Hospitalization for Heart Failure


Savor timi 53 hypoglycemia

SAVOR-TIMI 53: Hypoglycemia


Savor timi 53 hypoglycemia by baseline medication and hba 1c

SAVOR-TIMI 53: Hypoglycemia by Baseline Medication and HbA1c


Origin severe hypoglycemia and outcome

ORIGIN: Severe Hypoglycemia and Outcome


Accord hypoglycemia and mortality worse in standard group

ACCORD: Hypoglycemia and Mortality Worse in Standard Group


Esc easd guidelines glycemic control in diabetes

ESC/EASD Guidelines: Glycemic Control in Diabetes


Esc easd guidelines glycemic control in diabetes1

ESC/EASD Guidelines: Glycemic Control in Diabetes


In summary

In Summary


Abbreviations

Abbreviations


Abbreviations cont

Abbreviations (cont)


Abbreviations cont1

Abbreviations (cont)


References

References


References cont

References (cont)


References cont1

References (cont)


References cont2

References (cont)


References cont3

References (cont)


References cont4

References (cont)


  • Login